header-logo
Medical College of Wisconsin School of Graduate Studies U1-Research 2F Microscope Lab-Grad-hero
Komal Sharma

Komal Sharma

Graduate Student

Program

  • Interdisciplinary Program in Biomedical Sciences

Contact Information

Biography

Mentor: Michelle Riehle, PhD
Year Entered MCW: 2025
Previous Education: BS, Microbiology, University of Calcutta; MS, Environmental Sciences, University of Calcutta

Research Interests

I’m interested in working in the translational space, bridging discoveries from the lab to real-world impact. I enjoy turning data and experimental insights into practical tools that can guide decisions and improve outcomes.

Publications

Talukdar D, Raju YJ, Jana P, Sharma K, Babele P, Kothidar A, Ahrodia T, Narendrakumar L, Shyam KR, Singh U, Tanwar S, Harle S, Chaudhuri S, Raghavan S, Wadhwa N, Mukherjee S, Bhatnagar S, Das B; GARBH-Ini study group. Genomic insights into the potency and functional roles of Lactobacillus species in term and preterm births. Genomics. 2025 Jul;117(4):111063. doi: 10.1016/j.ygeno.2025.111063. Epub 2025 May 31. PMID: 40456421.

Talukdar D, Sarkar M, Ahrodia T, Kumar S, De D, Nath S, Jana P, Verma J, Mehta O, Kothidar A, Yodhaanjali JR, Sharma K, Bakshi S, Singh U, Kshetrapal P, Wadhwa N, Thiruvengadam R; Garbh-Ini study group; Nair GB, Bhatnagar S, Mukherjee S, Das B. Previse preterm birth in early pregnancy through vaginal microbiome signatures using metagenomics and dipstick assays. iScience. 2024 Oct 23;27(11):111238. doi: 10.1016/j.isci.2024.111238. PMID: 39569373; PMCID: PMC11576381.

Thapa B, De Sarkar N, Giri S, Sharma K, Kim M, Kilari D. Integrating PARP Inhibitors in mCRPC Therapy: Current Strategies and Emerging Trends. Cancer Manag Res. 2024 Sep 17;16:1267-1283. doi: 10.2147/CMAR.S411023. PMID: 39308935; PMCID: PMC11416116.

Obasi J, Sharma K, De Sarkar N, Antonarakis ES, Kilari D. Platinum Chemotherapy After PARP Inhibition in HRR-Deficient Metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2024 Dec;22(6):102187. doi: 10.1016/j.clgc.2024.102187. Epub 2024 Aug 10. PMID: 39241311. Obasi J, Sharma K, De Sarkar N, Antonarakis ES, Kilari D. Platinum Chemotherapy After PARP Inhibition in HRR-Deficient Metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2024 Dec;22(6):102187. doi: 10.1016/j.clgc.2024.102187. Epub 2024 Aug 10. PMID: 39241311.

Banerjee P., Sharma K., Nadda A. K., Mukhopadhayay A. (2024). Application of Potential Extremophilic Bacteria for Treatment of Xenobiotic Compounds Present in Effluents. In book: Microbes and Enzymes for Water Treatment and Remediation. CRC Press. doi: 10.1201/9781003517238-9

Ghosh, S.K., Adhikari, A., Mukhopadhyay, A., Bose, S., Sharma, K. (2022). COVID-19 Vaccination in India. In: Ghosh, S.K., Agamuthu, P. (eds) Health Care Waste Management and COVID 19 Pandemic. Springer, Singapore. https://doi.org/10.1007/978-981-16-9336-6_12


© 2025 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. MCW maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

MCW's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.